Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients
Open Access
- 16 May 2018
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 22 (3) , 242-245
Abstract
Anemia is a common complication of chronic kidney disease (CKD). There are various causes of renal anemia such as decreased production of erythropoietin, resistance to erythropoietin, shortened survival of red blood cells, and bone marrow fibrosis. Secondary hyperparathyroidism (SHPT) is a less recognized, but potentially significant cause of renal anemia in CKD patients. Parathyroid hormone (PTH) has been regarded as a uremic toxin that has multiple adverse effects, and its elevated levels have been associated with renal anemia in hemodialysis patients. Moreover, recent clinical studies have shown that the treatment of SHPT using either vitamin D receptor activators, calcimimetics, or parathyroidectomy leads to improvement of anemia, supporting the role of PTH in renal anemia. Emerging data have also indicated the involvement of bone‐derived fibroblast growth factor 23 in renal anemia. This review summarizes recent insights into the role of PTH in renal anemia and discusses the importance of treating SHPT in improving the control of renal anemia in hemodialysis patients.Keywords
This publication has 38 references indexed in Scilit:
- Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal diseaseClinical Nephrology, 2011
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidismNephrology Dialysis Transplantation, 2011
- Hyperparathyroïdie secondaire et anémie. Effets d’un calcimimétique sur le contrôle de l’anémie des hémodialysés chroniques. Étude piloteNephrologie & Therapeutique, 2011
- Iron, Inflammation, Dialysis Adequacy, Nutritional Status, and Hyperparathyroidism Modify Erythropoietic ResponseClinical Journal of the American Society of Nephrology, 2010
- Vitamin D deficiency and anemia in early chronic kidney diseaseKidney International, 2010
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2009
- 25-Hydroxyvitamin D Deficiency and Inflammation and Their Association with Hemoglobin Levels in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2009
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- High-dose alfacalcidol improves anaemia in patients on haemodialysisNephrology Dialysis Transplantation, 1997
- Effect of parathyroid hormone on erythropoiesis.Journal of Clinical Investigation, 1981